Increase in opiate prescription in Germany between 2000 and 2010: A study based on insurance data;Zunahme der opioidverordnungen in Deutschland zwischen 2000 und 2010: Eine studie auf der basis von krankenkassendaten

Deutsches Arzteblatt International

Volumn 110, Issue 4, 2013, Pages 45-51

  Schubert, Ingrid ^a   Ihle, Peter ^a   Sabatowski, Rainer ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; LEVOMETHADONE; METHADONE; OPIATE; NARCOTIC ANALGESIC AGENT;

AGE DISTRIBUTION; AGING; ARTICLE; CANCER DIAGNOSIS; GERMANY; HEALTH INSURANCE; HUMAN; OUTPATIENT; PAIN; PRESCRIPTION; PREVALENCE; RECIPIENT; TREATMENT DURATION; WORLD HEALTH ORGANIZATION; ADULT; CLINICAL PRACTICE; COMORBIDITY; DRUG USE; EPIDEMIOLOGY; FEMALE; MALE; MIDDLE AGED; NEOPLASMS; NURSING; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

ADULT; ANALGESICS, OPIOID; CAUSALITY; COMORBIDITY; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASMS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 84906329039     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0045     Document Type: Article

References (40)

1. Böger RH, Schmidt G: Analgetika. In: Schwabe U, Paffrath D (eds). Arzneiverordnungs-Report 2011. Berlin, Heidelberg: Springer Verlag 2011; 261-77.
2. Jarlbaek L, Anderson M, Hallas J, Engholm G, Kragstrup J: Use of Opioids in a Danish Population-Based Cohort of Cancer Patients. J Pain Symptom Manage 2005; 29: 336-43.
3. Leong M, Murnion B, Haber PS: Examination of opioid prescribing in Australia from 1992 to 2007. Internal Med J 2009; 39: 676-81.
4. Hamunen K, Paakkari P, Kalso E: Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009; 13: 954-62.
5. Ponizovsky A, Marom E, Zeldin A, Cherny N: Trends in opioid analgesics consumption, Israel, 2000-2008. Eur J Clin Pharmacol 2011; 67: 165-8.
6. Fredheim OMS, Skurtveit S, Breivik H, Borchgrevink PC: Increasing use of opioids from 2004 to 2007 -Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010; 14: 289-94.
7. Deshpande A, Furlan AD, Mailis-Gagnon A, Atlas S, Turk D: Opioids for chronic low-back pain. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD004959.
8. Noble M, Treadwell JR, Tregear SJ, et al.: Long-Term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD006605.
9. Breivik H: Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain 2005; 9: 127-30.
10. Kalso E, Allan L, Dellemijn PLI, Faura CC, Illias WK, Jensen TS, et al.: Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7: 381-6.
11. Sorgatz H, Hege-Scheuing G, Kopf A, et al.: Langzeitanwendung von Opioiden bei nichttumorbedingten Schmerzen. Dtsch Arztebl 2002; 99(33): A 2180-5.
12. Sorgatz H, Reinecke H, Lange K, et al.: Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen (LONTS). www.awmf.org/uploads/tx-szleitlinien/041-003l.pdf.
13. Marschall U, L'hoest H: Opioidtherapie in der Versorgungsrealität. Ein Beitrag zur Diskussion um ein weitverbreitetes Arzneimittel. In: Repschläger U, Schulte C, Osterkamp N (eds.). Gesundheitswesen aktuell 2011. Beiträge und Analysen. Düsseldorf; 2011: 242-69.
14. Garcia del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia del Pozo V: Trends in the consumption of opioids in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol, 2008; 64: 411-5.
15. Hamunen K, Laitinen-Parkkonen P, Paakkari P, et al.: What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008; 12: 705-15.
16. Moyano JR , Figuers A: The Medical Consumption of Opioids in Colombia, 1997-2007. J Pain Palliat Care Pharmacother 2010; 24: 367-73.
17. Bandieri E, Chiarolanza A, Luppi M. Magrini N, Marata AM, Ripamonti C: Prescription of opioids in Italy: Everthing, but the morphine. Ann Oncol 2009; 20: 961-70.
18. Dhalla I, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN: Prescribing of opioid analgesics and related mortality before and after the introduction of long-Acting oxycodone. CMAJ 2009; 181: 891-6.
19. Al-Asmari AI, Anderson RA, Cooper GA: Oxycodone-related fatalities in the west of Scotland. J Anal Toxicol 2009; 33: 423-32.
20. Bohnert AS, Valenstein M, Bair MJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305: 1315-21.
21. Dhalla IA, Persaud N, Juurlink DN: Facing up to the prescription opioid crisis. BMJ 2011; 343: 5142.
22. Volkow ND, McLellan TA: Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 2011; 305: 1346-7.
23. Fischer B, Argento E: Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician 2012; 15: ES191-203.
24. Gudin JA: Clinical strategies for the primary health care professional to minimize prescription opioid abuse. Postgrad Med 2012; 124: 131-8.
25. Rintoul AC, Dobbin MD, Drummer OH, Ozanne-Smith J: Increasing deaths involving oxycodone, Victoria, Australia, 2000-09. Inj Prev 2011; 17: 254-9.
26. Centers for Disease Control and Prevention. Drug overdose deaths -Florida, 2003-2009. Morb Mortal Wkly Rep 2011; 60: 869-72.
27. Dunn KM, Saunders KW, Rutter CM, et al.: Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 2010; 152: 85-92.
28. Paulozzi LJ, Kilbourne EM, Shah NG, et al.: A History of Being Prescribed Controlled Substances and Risk of Drug Overdose Death. Pain Medicine 2012; 13: 87-95.
29. Joransen DE, Ryan KM, Gilson AM, Dahl JL: Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283: 1710-14.
30. Miller M, Stürmer T, Azrael D, Levin R, Solomon DH: Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc 2011; 59: 430-8.
31. Solomon DH, Rassen JA, Glynn RJ, et al.: The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med 2010; 170: 1979-86.
32. Saunders KW, Dunn KM, Merril JO, et al.: Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med 2010, 25: 310-5.
33. Garbe E, Jobski K, Schmid U: Utilisation of transdermal fentanyl in Germany from 2004 to 2006. Pharmacoepidemiol Drug Saf 2012; 21: 191-8.
34. Arzneimittelkommission der Deutschen Ärzteschaft -UAW-News International: Die unkritische Anwendung von Fentanylpflastern erhöht das Risiko für schwerwiegende Nebenwirkungen. Dtsch Arztebl 2012; 109(14): A 724.
35. Sabatowski R, Scharnagel R: Comment on the report on Utilisation of transdermal fentanyl in Germany from 2004 to 2006 by Edeltraut Garbe et al. Pharmacoepidemiol Drug Saf 2012; 21: 902-3.
36. Samaha AN, Robinson TE: Why does the rapid delivery of drugs to the brain promote addiction? Trends Pharmacol Sci 2005; 26: 82-7.
37. Porada S: REMS; Red tape, or a remedy for opioid abuse? J Fam Pract 2011; 60, Suppl 2: S55-62.
38. Nalamachu SR, Narayana A, Janka L: Long-Term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-Tolerant patients. Curr Med Res Opin 2011; 27: 751-60.
39. Portenoy RK, Messina J, Xie F, Peppin J: Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-Treated patients with chronic low back pain: A randomized, placebo-controlled study. Curr Med Res Opin 2007; 23: 223-33.
40. Passik SD, Messina J, Golsorkhi A, Xie F: Abberant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage 2011; 41: 116-25.